Skip to content

DOKTER P. DE LOECKER

Active Private limited companyfounded 2003active for 23 yearsLange Leemstraat 241, 2018 AntwerpKBO/BCE: BE 0859.757.916

Lifetime

19 annual accounts with figures on one time axis, 22 filings since 2004
Gross marginpeak €457,441 (2010)
€181,510▲ 51.0%
Resultpeak €154,987 (2011)
€77,798▲ 115%
Equitypeak €893,976 (2018)
€483,868▼ 10.3%
Debts
€225,589▲ 12.6%
Staffpeak 0.5 FTE (2014)
-not published
Board1 name since 2003
- 
Documentsfilings and deeds
23-09-202538 days before the deadline
2025micro format
Gross margin from €120,182 to €181,510Result from €36,113 to €77,798Dividend €133,300Cash from €26,186 to €56,631

Key points

from the 2025 annual accounts

Equity

€483,868 ▼ 10.3%
539,3702024+77,798Profit-133,300Dividend483,8682025

DOKTER P. DE LOECKER paid out €133,300 in dividends. That is 171% of the 2025 profit.

Turnover

≈ €340,000 estimated

The micro format states no turnover.

Filings

22 annual accounts 5 days past the deadline
deadline20102020

2026 accounts not filed: deadline was 31-10-2026.

Checked score

89
Excellent
Financially stronger than 27% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 24,173 companies (NACE 86, micro).

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.3% 01-2025: 0.6%▲ +0.3 percentage points vs 12-2024 02-2025: 0.6%● unchanged vs 01-2025 03-2025: 0.8%▲ +0.2 percentage points vs 02-2025 04-2025: 1.5%▲ +0.7 percentage points vs 03-2025 05-2025: 1.5%● unchanged vs 04-2025 06-2025: 1.5%● unchanged vs 05-2025highest value 07-2025: 1.4%▼ -0.1 percentage points vs 06-2025 08-2025: 1.4%● unchanged vs 07-2025 09-2025: 0.5%▼ -0.9 percentage points vs 08-2025 10-2025: < 0.1%▼ -0.5 percentage points vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026lowest value 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: 0.1%▲ +0.1 percentage points vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026

Financial strength
Strong

Solvency
77-4equity 51.5% of total assets
Liquidity
49+2short-term debt 24.0% · cash 6.0%
Profitability
79+6return on assets 8.3%

Score breakdown

raises risk
Figures for financial year 2025 (filed on 23-09-2025)
1 financial year not filed after the legal deadline; 1 of the last 3 accounts late
lowers risk
Sector: Human health activities (NACE 86)
Size: total assets €939,457
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 41% of them on solvency, 17% on liquidity, 25% on profitability and 26% on growth.

The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-03-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 20,136 companies had the same profile as DOKTER P. DE LOECKER has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

That fits the bankruptcy probability of DOKTER P. DE LOECKER itself: 0.1% within 12 months.

Test of the method

The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,136 companies, not a prediction for DOKTER P. DE LOECKER. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €40,000 on 30-day terms is acceptable

Liquidity is insufficient, with a current ratio of 0.7 (0.76 in 2024), below 1. Short-term debt is 24% and cash 6% of total assets. 48.5% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Figures for financial year 2025 (filed on 23-09-2025)
NBB · annual accounts
lowers risk · Size: total assets €939,457
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · 1 financial year not filed after the legal deadline; 1 of the last 3 accounts late
NBB · filings
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 23-09-2025, 38 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2026
not filed
2025
38 days early
2024
298 days late
2023
29 days early
2022
20 days early
2021
26 days early
2020
19 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 6 accounts on average 28 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

last known board
DL
Director, until 2023
  • DE LOECKER Peter Alfons Josephdeed of 29-11-2023
Board & ownership

Recent changes

Change of role: DE LOECKER Peter Alfons Joseph, from manager to director DE LOECKER Peter Alfons Joseph is a shareholder · General meeting of 23-11-2023 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0859757916
New establishment in Antwerp Dr. P. De Loecker, Sint-Jozefstraat 5
Incorporation published on 31-07-2003 · Gazette deed
All 33 events

Comparable companies

same main activity, similar in size and age
Company Total assets Gross margin Solvency Staff
DOKTER P. DE LOECKER Antwerp €0.9m €181,510 51.5% -
DOKTERS LUDO VAN BREUSEGEM & PETRA JANSSENS Schilde €1.0m €176,363 98.8% -
DR. MIEKE DEVOS Mechelen €0.9m €180,352 72.9% -
HAPATTA Beerse €0.8m €180,052 78.1% -
DR JANSEN - DR DE LOOR Kontich €0.9m €203,256 92.6% -
DR. ANN VERMEIREN Hoogstraten €0.9m €190,107 96.7% -
DR. DE CLERCK ERIK Rumst €0.9m €193,749 55.7% -

These companies have the same main activity as DOKTER P. DE LOECKER: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €829,000 and €1m, founded between 2000 and 2006.

Official details

Source: KBO
Status
Active since 24-07-2003Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment units
2.187.809.7592018 Antwerp, since 24-07-2003
2.221.420.7542018 Antwerp, since 12-08-2013
Financial year end
31 March
Peppol
Reachable since 24-11-2023
Company details

Annual accounts to 31-03-2025

Total assets
€939,457▼ 3.1%
Filing
Filed on 23-09-2025
Financials

Insights on DOKTER P. DE LOECKER

DOKTER P. DE LOECKER files the micro format. That format states no turnover. The gross margin rose from €131,697 in 2007 to €181,510 in 2025.

The balance sheet grew most from 2010 to 2012 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DOKTER P. DE LOECKER

What is the company number of DOKTER P. DE LOECKER?
The company number of DOKTER P. DE LOECKER is 0859.757.916. The VAT number is the same number with BE in front: BE 0859.757.916.
Where is DOKTER P. DE LOECKER based?
The registered office is at Lange Leemstraat 241, 2018 Antwerp.Company details
What does DOKTER P. DE LOECKER do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DOKTER P. DE LOECKER?
DOKTER P. DE LOECKER is a private limited company (BV).
When was DOKTER P. DE LOECKER founded?
DOKTER P. DE LOECKER was founded on 24-07-2003.
Is DOKTER P. DE LOECKER still active?
Yes, DOKTER P. DE LOECKER is an active enterprise in the KBO register.
What is the turnover of DOKTER P. DE LOECKER?
The turnover in financial year 2025 is ≈ €340,000. This figure is estimated from the gross margin of €181,510 and 42 comparable companies (NACE 86220). It probably lies between €290,000 and €440,000.Financials
Is DOKTER P. DE LOECKER profitable?
In financial year 2025, DOKTER P. DE LOECKER made a profit of €77,798.
Where can I find the annual accounts of DOKTER P. DE LOECKER?
DOKTER P. DE LOECKER filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.